The study, published in the Journal of Clinical Investigation, offers hope of more alternative approaches to killing cancer cells that may have become resistant to the traditional chemotherapy treatments.
A number of antibody treatments for cancer have been developed over the last decade and some of them are a huge step forward in treatment. The current research identifies how some of these kill cancer cells and provides exciting insights into how other antibodies that use this mechanism might be developed.
Dr Mark Cragg, from the University of Southampton, who together with Prof. Tim Illidge, from the University of Manchester, led the research said: “Our findings are significant and open up the possibility of applying the knowledge of how antibodies can be developed to trigger cell death and may enable us to design treatments for other cancers.”
The large study was funded by AICR, Leukaemia Research, Cancer Research UK and Tenovus. AICR's Dr Mark Matfield said: “The discovery of a new mechanism by which cancer cells kill themselves is an important step forward in cancer research. Killing the cancer cells is the basis of all successful cancer treatments.” link....
No comments:
Post a Comment